Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.58 |
| ▸ | NMT1 | P30419 | 6/20 | 0.58 |
| ▸ | NMT2 | O60551 | 5/20 | 0.58 |
| ▸ | TLR2 | O60603 | 2/20 | 0.55 |
| ▸ | CTSL | P07711 | 1/20 | 0.52 |
| ▸ | NOD1 | Q9Y239 | 4/20 | 0.50 |
| ▸ | FAAH | O00519 | 1/20 | 0.46 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.45 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1280087 | 1.00 | SLC6A5 (0.58) | SLC6A5NMT1NMT2TLR2CTSL | |
| SCHEMBL1673186 | 1.00 | SLC6A5 (0.58) | SLC6A5NMT1NMT2TLR2CTSL | |
| SCHEMBL1673194 | 1.00 | SLC6A5 (0.58) | SLC6A5NMT1NMT2TLR2CTSL | |
| SCHEMBL30905802 | 1.00 | SLC6A5 (0.58) | SLC6A5NMT1NMT2TLR2CTSL | |
| SCHEMBL30399641 | 1.00 | SLC6A5 (0.58) | SLC6A5NMT1NMT2TLR2CTSL | |
| Acetic Acid SCHEMBL29600169 | 0.98 | SLC6A5 (0.56) | SLC6A5NMT1NMT2TLR2CTSL | |
| SCHEMBL23227556 | 0.97 | CTSL (0.56) | SLC6A5NMT1NMT2TLR2CTSL | |
| SCHEMBL31307622 | 0.97 | SLC6A5 (0.54) | SLC6A5NMT1NMT2TLR2CTSL | |
| SCHEMBL31307690 | 0.97 | SLC6A5 (0.54) | SLC6A5NMT1NMT2TLR2CTSL | |
| SCHEMBL31307638 | 0.97 | SLC6A5 (0.54) | SLC6A5NMT1NMT2TLR2CTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1434 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260088866-A1 | LOW-COMPLEXITY BEAMFORMING USING COVARIANCE COMPRESSION | NOKIA SOLUTIONS & NETWORKS OY (FI) | 2026-03-26 | — | — | US | claimed |
| EP-4716110-A1 | LOW-COMPLEXITY BEAMFORMING USING COVARIANCE COMPRESSION | Nokia Solutions and Networks Oy (FI) | 2026-03-25 | — | — | EP | claimed |
| EP-4698272-A1 | USE OF CHARGED AIR IONS IN COSMETIC TREATMENTS | Wetling IP AEAM Ltd (VG) | 2026-02-25 | — | — | EP | claimed |
| EP-4110276-B1 | COMPOSITIONS COMPRISING ALKANEDIOLS | SYMRISE AG (DE) | 2026-01-28 | — | — | EP | claimed |
| EP-4312981-B1 | EDIBLE ORAL COMPOSITIONS COMPRISING HOPS | PROCTER & GAMBLE (US) | 2025-11-05 | — | — | EP | claimed |
| WO-2025202997-A1 | AN ANTI-AGING EYE CREAM | L'OREAL (FR) | 2025-10-02 | — | — | WO | claimed |
| US-20250302721-A1 | ANTI-AGING EYE CREAM | L'OREAL (FR) | 2025-10-02 | — | — | US | claimed |
| CN-114092760-B | Self-adaptive feature fusion method and system in convolutional neural network | 通号通信信息集团有限公司 | 2025-06-10 | — | — | CN | claimed |
| WO-2025096781-A1 | METHODS AND COMPOSITIONS FOR PROVIDING CUSTOMIZED SKIN REGIMENS | VIBRANT HOLDINGS, LLC (US) | 2025-05-08 | — | — | WO | claimed |
| CN-114722520-B | Planetary bearing intelligent fault diagnosis method based on enhanced dictionary learning | 清华大学 | 2025-05-02 | — | — | CN | claimed |
| US-6492326-B1 | CONTAINING A PENTAPEPTIDE | THE PROCTER & GAMBLE COMPANY | 2002-12-10 | — | — | US | claimed |
| US-6444647-B1 | COMPOSITION COMPRISING SAFE AND EFFECTIVE AMOUNTS OF VITAMIN B3 COMPOUND AND ADDITIONAL SKIN CARE ACTIVE SELECTED FROM FARNESOL AND/OR PHYTANTRIOL, AND DERMATOLOGICALLY ACCEPTABLE EMULSION CARRIER | THE PROCTER & GAMBLE COMPANY | 2002-09-03 | — | — | US | claimed |
| EP-1171081-A2 | SKIN CARE COMPOSITIONS CONTAINING COMBINATION OF SKIN CARE ACTIVES | THE PROCTER & GAMBLE COMPANY (US) | 2002-01-16 | — | — | EP | claimed |
| EP-1171089-A2 | SKIN CARE COMPOSITIONS CONTAINING COMBINATION OF SKIN CARE ACTIVES | THE PROCTER & GAMBLE COMPANY (US) | 2002-01-16 | — | — | EP | claimed |
| EP-1171093-A2 | SKIN CARE COMPOSITIONS CONTAINING COMBINATION OF SKIN CARE ACTIVES | The Procter & Gamble Company (US) | 2002-01-16 | — | — | EP | claimed |
| WO-2000062745-A2 | SKIN CARE COMPOSITIONS CONTAINING COMBINATION OF SKIN CARE ACTIVES | THE PROCTER & GAMBLE COMPANY (US) | 2000-10-26 | — | — | WO | claimed |
| WO-2000062743-A2 | SKIN CARE COMPOSITIONS CONTAINING COMBINATION OF SKIN CARE ACTIVES | THE PROCTER & GAMBLE COMPANY (US) | 2000-10-26 | — | — | WO | claimed |
| WO-2000062740-A2 | SKIN CARE COMPOSITIONS CONTAINING COMBINATION OF SKIN CARE ACTIVES | THE PROCTER & GAMBLE COMPANY (US) | 2000-10-26 | — | — | WO | claimed |
| WO-2000062741-A2 | SKIN CARE COMPOSITIONS CONTAINING COMBINATION OF SKIN CARE ACTIVES | THE PROCTER & GAMBLE COMPANY (US) | 2000-10-26 | — | — | WO | claimed |
| WO-2000062744-A2 | SKIN CARE COMPOSITIONS CONTAINING COMBINATION OF SKIN CARE ACTIVES | THE PROCTER & GAMBLE COMPANY (US) | 2000-10-26 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260088866-A1 | LOW-COMPLEXITY BEAMFORMING USING COVARIANCE COMPRESSION | CACNA1G, CACNA1C, PIEZO1 | SLC6A5 2334/4885NMT1 3244/4885NMT2 3087/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.